Net Cash Provided by (Used in) Financing Activities of ESSA Pharma Inc. from 30 Sep 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
ESSA Pharma Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 30 Sep 2019 to 31 Dec 2024.
  • ESSA Pharma Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Dec 2024 was $0, a 100% decline year-over-year.
  • ESSA Pharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $925,510.
  • ESSA Pharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $68,157, a 127% decline from 2022.
  • ESSA Pharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $252,735.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

ESSA Pharma Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $0 -$196,659 -100% 01 Oct 2024 31 Dec 2024 10-Q 11 Feb 2025 2025 Q1
Q4 2023 $196,659 +$181,007 +1156% 01 Oct 2023 31 Dec 2023 10-Q 11 Feb 2025 2025 Q1
Q4 2022 $15,652 -$83,659 -84% 01 Oct 2022 31 Dec 2022 10-Q 13 Feb 2024 2024 Q1
Q4 2021 $99,311 -$51,621 -34% 01 Oct 2021 31 Dec 2021 10-Q 07 Feb 2023 2022 Q1
Q4 2020 $150,932 +$4,187,110 01 Oct 2020 31 Dec 2020 10-Q 03 Feb 2022 2022 Q1
Q4 2019 $4,036,178 01 Oct 2019 31 Dec 2019 10-Q 11 Feb 2021 2021 Q1

ESSA Pharma Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $925,510 +$993,667 01 Oct 2023 30 Sep 2024 10-K 17 Dec 2024 2024 FY
2023 $68,157 -$320,892 -127% 01 Oct 2022 30 Sep 2023 10-K 17 Dec 2024 2024 FY
2022 $252,735 -$141,738,018 01 Oct 2021 30 Sep 2022 10-K 12 Dec 2023 2023 FY
2021 $141,990,753* +$100,214,128 01 Oct 2020 30 Sep 2021 10-K 13 Dec 2022 2022 FY
2020 $41,776,625 -$8,787,295 -17% 01 Oct 2019 30 Sep 2020 10-K 18 Nov 2021 2021 FY
2019 $50,563,920 01 Oct 2018 30 Sep 2019 10-K 18 Nov 2021 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.